SPD Development Company Ltd
Bedford, Bedfordshire, MK44 3UP, United Kingdom
NCT Number: NCT03122951
The Clearblue® Advanced Ovulation Test is designed for home use by women who are either planning or trying for a pregnancy.
The purpose of this protocol is to demonstrate that lay-users representative of the target user population are able to use the product in the intended user environment.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Bedford, Bedfordshire, MK44 3UP, United Kingdom
The Clearblue Advanced Ovulation Test is designed for home use by women who are trying to get pregnant now or in the near future. It identifies those days in a woman's cycle on which intercourse is most likely to lead to conception.
The product defines three phases of fertility through urine hormone measurement: Low (small chance of conceiving), High (increased chance of conceiving) which is achieved by the detection of a rise in the level of estrone-3-glucuronide and Peak (highest chance of conceiving) which provides an early warning of impending ovulation through detection of the luteinising hormone surge which precedes it by 24 - 36 hours.
This protocol aims to demonstrate the successful usage of the Clearblue Advanced Ovulation Test product by lay-users in the intended environment.
Elements of system usability, product satisfaction and ease of use will be used to assess overall product performance in lay-user hands.
Lay users will be required to user the product according to the instructions for use for a mimimum of 1 complete menstrual cycle after which they will be required to provide feedback on product use.
A usability scale which focusses on providing subjective feedback from users. This is a simple ten-item attitude Likert scale which each volunteer will complete after 4 weeks of product use. The primary endpoints of this study will focus on the use of this scoring scale to determine the usability of the product in lay-user hands.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Female Aged 18 to 45 years Trying to conceive, planning to conceive in the next year or interested in using an ovulation testing system.
Willing to provide written informed consent to participate in the study. Has menstrual cycles.
Exclusion criteria
Pregnant, recently pregnant or breastfeeding Diagnosed with Polycystic Ovarian Syndrome Use of hormonal contraception Use of hormone replacement therapy Use of any other medical treatment for fertility such as ovulation drugs, artificial insemination, assisted fertility such as IVF, ICSI Currently or previously employed by SPD, Alere, Unipath or P and G, or affiliates Has an immediate relative currently or previously employed by SPD, Alere, Unipath or P and G or affiliates
-
Normal use of The Clearblue® Advanced Ovulation Test according to Information for use instructions
Time frame: 4 weeks
≥95% of volunteers score 68 or higher on the usability scale after 4 weeks of usage or at the point of withdrawal from the study
Time frame: 4 weeks
agreement between lay-user interpretation of the test result and the test result as stored in the users account
Time frame: 4 weeks
Intra and inter-volunteer experience of using the product as recorded on a satisfaction scale in the volunteer diary
Time frame: 4 weeks
The average number of times an individual volunteer interacts with the product throughout a cycle and an understanding of when the interaction is at its highest
Time frame: 4 weeks
The cumulative Likert scored for the end of study system usability questions
SPD Development Company Limited
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.